20 articles
Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.
A completed RCT tests whether small-sided football sessions 3x/week improve glucose control and metabolic health in T2DM patients on GLP-1 and SGLT2 drugs.
Stanford study tests whether GLP-1 drug exenatide can restore insulin function and promote weight loss in people with prediabetes.
176-person trial tested whether pioglitazone could improve liver health by targeting insulin resistance in patients with fatty liver disease.
Danish researchers studied how moderate exercise affects glucose regulation in diabetics versus healthy controls during fasted workouts.
Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.
UCSF study reveals how metformin and trimethoprim interfere with thiamine uptake, potentially affecting energy metabolism.
411-person study shows digital insulin delivery system helps optimize glucose control through automated dose tracking and mobile integration.
275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.
Eli Lilly's phase 3 trial pits a novel weekly basal insulin against the gold-standard daily insulin degludec in type 1 diabetes patients.
A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.
84-person study reveals how targeted nutrition counseling impacts blood sugar, weight, and heart health in diabetic patients.
Small study explores whether eating within 9-hour windows can improve blood sugar control and metabolic health in diabetic patients.
Study reveals how gastric surgery rapidly restores blood sugar control in diabetic patients through metabolic changes, not just weight reduction.
A Phase 1 trial tests whether lowering compensatory hyperinsulinemia with diazoxide improves glucose and lipid metabolism in NAFLD patients.
Major prevention trial proves diet and exercise dramatically reduce diabetes onset compared to medication alone.
12-week resistance training study shows promise for managing diabetes and preventing muscle loss in older adults.
German researchers test whether natural foods plus digital coaching can match diabetes remission rates of formula diets.
Clinical trial tested whether metformin could improve surgical outcomes and reduce hospital stays in non-diabetic older patients.
Major trial tests whether diabetes drug metformin can prevent frailty syndrome that affects millions of aging adults.
